Advent Life Sciences

Advent Life Sciences is a prominent trans-Atlantic venture investor specializing in fostering innovative Life Sciences businesses in the UK, Europe, and the USA. Established in 2009, the company prides itself on an esteemed team known for their entrepreneurial and investment triumphs in translating groundbreaking science into approved medicines and medical products. The focus lies in backing early and mid-stage companies with a first-in-class or best-in-class approach, primarily centered around investments in new drug discovery - encompassing small molecules, biologics, and new modalities - as well as med-tech, enabling technologies, and vaccines. The company's impressive history encompasses fourteen approved medicines and products developed since the year 2000, to the benefit of patients, physicians, and investors. As seasoned entrepreneurs and pragmatic investors, Advent Life Sciences leverages its intellectual capital and extensive network to offer unwavering support to every investment. Through close collaboration with management teams, the company endeavors to bring innovation to patients while achieving superior financial returns. This aligns with their enduring commitment to realizing the vision of its partner companies, establishing a track record of success in delivering advancements to the healthcare sector.